carbenoxolone and uvaol

carbenoxolone has been researched along with uvaol* in 1 studies

Other Studies

1 other study(ies) available for carbenoxolone and uvaol

ArticleYear
Microbial transformation and inhibitory effect assessment of uvaol derivates against LPS and HMGB1 induced NO production in RAW264.7 macrophages.
    Bioorganic & medicinal chemistry letters, 2022, 02-15, Volume: 58

    For the discovery of new pentacyclic triterpenes as a potential anti-inflammatory agent, microbial transformation of uvaol by Penicilium griseofulvum CICC 40293 and Streptomyces griseus ATCC 13273 was investigated. Stereoselective hydroxylation and epoxidation reactions were observed in the biotransformation. Moreover, six new metabolites were isolated and structurally elucidated by HR-ESI-MS and NMR spectrum. All the compounds were evaluated upon the inhibitory effects of nitric oxide (NO) release in RAW 264.7 cells induced by lipopolysaccharide (LPS) and high-mobility group box 1 (HMGB1). Among them, compound 3 (13, 28-epoxy-3β, 7β, 21β-trihydroxy-urs-11-ene) with the unique epoxy structure and compound 5 (3β, 21β, 24, 28-tetrahydroxy-urs-12-en-30-oic acid), exhibited a considerable inhibitory effect on both models while compound 2 (urs-12-ene-3β, 7β, 21β, 28-tetraol) showed a significant bias in the LPS-induced inflammatory response with IC

    Topics: Animals; Dose-Response Relationship, Drug; HMGB1 Protein; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; Nitric Oxide; RAW 264.7 Cells; Structure-Activity Relationship; Triterpenes

2022